BioContact Québec

BioContact Québec

October 06, 2005 09:00 ET

Media Advisory/Today at BioContact

QUEBEC CITY, QUEBEC--(CCNMatthews - Oct. 6, 2005) - BioContact Quebec 2005 is entering its second day. On the agenda today:



LUNCHEON CONFERENCE - CANADIAN BIOPHARMACEUTICAL MARKET OVERVIEW
BALL ROOM - 13H - 14H

Cameron Groome, Managing Director, First Associates Investments
Robert Wilson, Vice-President, Research Capital Corporation
Vince Mazza, Director, Scotia Capital Inc.
Moderator: Rene Douville, Vice-President, RBC Technology Ventures
1:15pm - 2 pm

PRESENTING COMPANIES TODAY'S ARE:

Cardianove Inc.
YM BioSciences
PureCell Technologies Inc
Inimex Pharmaceuticals, Inc.
Chromos Molecular Systems Inc.
Montreal International
BDC - Venture Capital / Technology Seed Investments
Ecopia Biosciences Inc.
Forbes Medi-Tech Inc.
Celmed BioSciences Inc.
Axcan Pharma inc.
DNA LandMarks Inc.
Belgian Trade Commission / Consulat general de Belgique
Groupe TSX
Aeterna Zentaris Inc.
PreMD Inc. (formerly IMI Int'l Medical Innov)
Odyssey Thera, Inc.
SemBioSys Genetics Inc.
ERA
Research Capital Corporation
Bioniche Life Sciences
Medicure Inc.
OncoGenex Technologies Inc.
Xenon Pharmaceuticals Inc.
IL Therapeutics
Genizon BioSciences
Genome Canada
Societe generale de financement du Quebec (SGF)
Celator Pharmaceuticals, Inc. - New Jersey
Novadaq Technologies
OPi
Axela Biosensors Inc.
Biogen Idec Canada Inc.
Tm Bioscience Corporation
Genome Quebec
RBC - Financial Group / RBC - Groupe Financier
MethylGene Inc.
Resverlogix Corp.
Procyon Biopharma, Inc.
StemPath Inc
AviGenics, Inc.
Warnex Inc.
National Research Council - IRAP / Conseil national de recherche -
PARI
Fonds de solidarite FTQ
MGI Pharma, Inc.
Vasogen Inc.
Prometic Life Sciences Inc.
LAB International Inc.
Stressgen Biotechnologies
Northern Therapeutics Inc.
Canada's Research-Based Pharma Companies
Investissement Quebec
Enobia Pharma
Biocode Hycel S.A.
AlgoNomics
WEX Pharmaceuticals Inc.
Chemokine Therapeutics corp
Neptune Technologies & Bioressources Inc.
PricewaterhouseCoopers - Montreal
Marsh Canada Limited - Toronto
Innodia inc.
Eurogentec S.A.
SFBC Anapharm (a subsidiary of SFBC International)
NeurAxon Inc
Mimetogen Pharmaceuticals
Delphi Genetics SA
KPMG LLP - Montreal
Gowling Lafleur Henderson LLP - Ottawa
Paladin Labs Inc.
Ulysses Pharmaceutiques
Biovail Contract Research
Neurochem Inc.
Supratek Pharma Inc.
Caprion Pharmaceuticals, Inc.
Desjardins Ducharme, S.E.N.C.R.L.
Bereskin & Parr
Theratechnologies
Zentech SA
MDS Pharma Services
Neuromed Technologies Inc.
Protox Therapeutics Inc.
Biognos AB
Merck Frosst Ltd. - Montreal
Choate, Hall & Stewart LLP
Transition Therapeutics Inc
Adaltis Inc.
Genomics One Corporation
Stem Cell Therapeutics Corp
Twinstrand Therapeutics Inc.
ERA7 Information Technologies S.L.
Quintiles Canada, inc.
Ogilvy Renault - Toronto
Tranzyme Pharma Inc.
Advitech inc.
McGill University and Genome Quebec Innovation Centre
Allon Therapeutics Inc.
Viventia Biotech Inc.
PainCeptor Pharma Corp.
First Associates Investments inc.
ROBIC


BioContact Quebec 2005 is a unique opportunity to get the inside scoop on the biopharmaceutical sector. A detailed symposium agenda and a list of all participants are available on BioContact Quebec 2005 website: www.biocontact.qc.ca.

MEDIA

A media room will be available throughout the conference. A communications officer will be on-site to help media schedule interviews and meetings.

Contact Information

  • BioContact Quebec 2005
    Anie Perrault
    (514) 258-7629